Human DNA methyltransferase gene-transformed yeasts display an inducible flocculation inhibited by

Kei-Ichi Sugiyama1, Makiko Takamune1, Hiroko Furusawa1

  • 1Division of Genetics and Mutagenesis, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.

Insights

Mammalian DNA methyltransferases (DNMTs) functionally expressed in yeast. These DNMT-transformed yeast strains show potential for screening novel DNMT inhibitors by affecting flocculation.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Yeast Genetics

Background:

  • Mammalian DNA methyltransferases (DNMTs) are crucial for epigenetic regulation.
  • The functional expression of mammalian DNMTs in yeast, which lack endogenous DNMTs, is not well understood.

Purpose of the Study:

  • To investigate the functional expression of human DNMT1, DNMT3A, and DNMT3B genes in Saccharomyces cerevisiae.
  • To evaluate the utility of DNMT-transformed yeast strains for screening DNMT inhibitors.

Main Methods:

  • Cotransformation of yeast with human DNMT genes under a galactose-inducible promoter (GAL1).
  • Assessment of cell growth and flocculation in response to the DNMT inhibitor 5-aza-2'-deoxycytidine (5AZ).

Main Results:

  • Transformed yeast strains exhibited growth inhibition in galactose- and glucose-containing media, independent of 5AZ.
  • 5AZ dose-dependently interfered with yeast flocculation, suggesting DNMT activity influenced FLO1 gene expression.
  • 2'-deoxycytidine did not affect flocculation.

Conclusions:

  • Human DNMT genes are functionally expressed in yeast.
  • DNMT-transformed yeast strains provide a viable system for in vivo screening of DNMT inhibitors.

Related Concept Videos